161 related articles for article (PubMed ID: 3115982)
1. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways.
Hannun YA; Greenberg CS; Bell RM
J Biol Chem; 1987 Oct; 262(28):13620-6. PubMed ID: 3115982
[TBL] [Abstract][Full Text] [Related]
2. Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies.
Krishnamurthi S; Patel Y; Kakkar VV
Biochim Biophys Acta; 1989 Feb; 1010(2):258-64. PubMed ID: 2492201
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets.
Hannun YA; Loomis CR; Merrill AH; Bell RM
J Biol Chem; 1986 Sep; 261(27):12604-9. PubMed ID: 3462188
[TBL] [Abstract][Full Text] [Related]
4. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the diacylglycerol kinase inhibitor R59022 on thrombin versus collagen-induced human platelet secretion.
Joseph S; Krishnamurthi S; Kakkar VV
Biochim Biophys Acta; 1988 Apr; 969(1):9-17. PubMed ID: 2832002
[TBL] [Abstract][Full Text] [Related]
6. Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C.
Siess W; Lapetina EG
Biochem J; 1988 Oct; 255(1):309-18. PubMed ID: 3143357
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism.
Siess W; Lapetina EG
Biochem J; 1989 Oct; 263(2):377-85. PubMed ID: 2574568
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the oxidative burst in human neutrophils by sphingoid long-chain bases. Role of protein kinase C in activation of the burst.
Wilson E; Olcott MC; Bell RM; Merrill AH; Lambeth JD
J Biol Chem; 1986 Sep; 261(27):12616-23. PubMed ID: 3017982
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.
Hashizume T; Sato T; Fujii T
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):243-7. PubMed ID: 1540140
[TBL] [Abstract][Full Text] [Related]
10. Use of D-erythro-sphingosine as a pharmacological inhibitor of protein kinase C in human platelets.
Khan WA; Mascarella SW; Lewin AH; Wyrick CD; Carroll FI; Hannun YA
Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):387-92. PubMed ID: 1898331
[TBL] [Abstract][Full Text] [Related]
11. Response of aequorin-loaded platelets to activators of protein kinase C.
Ware JA; Saitoh M; Smith M; Johnson PC; Salzman EW
Am J Physiol; 1989 Jan; 256(1 Pt 1):C35-43. PubMed ID: 2912135
[TBL] [Abstract][Full Text] [Related]
12. The antioxidant butylated hydroxytoluene (BHT) inhibits the dioctanoylglycerol-evoked platelet response but potentiates that elicited by ionomycin.
Ruzzene M; Francesconi M; Donella-Deana A; Alexandre A; Deana R
Arch Biochem Biophys; 1992 May; 294(2):724-30. PubMed ID: 1314548
[TBL] [Abstract][Full Text] [Related]
13. Delayed accumulation of diacylglycerol in platelets as a mechanism for regulation of onset of aggregation and secretion.
Werner MH; Hannun YA
Blood; 1991 Jul; 78(2):435-44. PubMed ID: 2070079
[TBL] [Abstract][Full Text] [Related]
14. Phorbol esters sensitize platelets to activation by physiological agonists.
Siess W; Lapetina EG
Blood; 1987 Nov; 70(5):1373-81. PubMed ID: 3663938
[TBL] [Abstract][Full Text] [Related]
15. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
16. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
17. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
[TBL] [Abstract][Full Text] [Related]
19. Effects of trifluoperazine on platelet activation.
Ardlie NG; Boatwright C; Garrett J; McGuiness JA
Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
[TBL] [Abstract][Full Text] [Related]
20. N,N,N-trimethylsphingosine modifies aggregatory response and ATP release from platelets in whole blood.
Knöfler R; Urano T; Takada Y; Takada A
Thromb Res; 1994 Nov; 76(4):323-32. PubMed ID: 7871492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
